E

Elypta

24 employees

Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring

Basic info

Industry

biotechnology research

Sectors

systems biology
Biotechnology
Health Diagnostics
diagnostics
renal cell carcinoma
Health Care
biomarkers
urology
cancer
liquid biopsy
oncology

Date founded

2017

Funding rounds raised

Total raised

$21M

from 18 investors over 18 rounds

E

Elypta raised $1M on March 28, 2023

Investors: The Roddenberry Foundation

E

Elypta raised $21M on June 20, 2022

Investors: Hillclimber, Bonnier Ventures, Navigare Ventures, Industrifonden, Chalmers Ventures, Norrsken VC and Nina Capital

E

Elypta raised $6.8M on January 23, 2020

Investors: Chalmers Ventures, Industrifonden, Nina Capital, Sciety and Norrsken VC

E

Elypta raised $33K on October 1, 2019

Investors: EIT Health

E

Elypta raised $2.6M on January 1, 2019

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

E

Elypta raised $1.8M on June 11, 2018

Investors: Navigare Ventures and Chalmers Ventures

E

Elypta raised $344K on June 1, 2017

Investors: Navigare Ventures

FAQ